Feed aggregator

Cases of Borna disease virus 1, or BoDV-1, are extremely rare in humans, but in those who develop disease the outcome is severe, almost always resulting in fatal encephalitis or inflammation in the brain.

​Humans and most other organisms have internal biological clocks that track the daily cycle of sunrise and sunset. These clocks help time our sleep, metabolism and other essential body functions over the course of a day, creating daily patterns called circadian rhythms.

Breast cancer is the most common form of cancer in women. According to the World Health Organization, in 2022, around 2.3 million women were diagnosed with breast cancer, and the disease caused about 670,000 deaths worldwide.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer - and identified a promising strategy to overcome that resistance.

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators.

Statistics show clear differences in the population's immune system according to sex: men are more susceptible to infections and cancers, while women have stronger immune responses, which translate, for example, into better responses to vaccines.

Stroke is one of the leading causes of death worldwide. Its recovery is often challenging as most of the stroke survivors remain chronically disabled, with motor deficits affecting a significant percentage of patients.

Alligator Bioscience, a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today provided a brief update regarding mitazalimab.

A new study co-authored by two University of Wisconsin–Madison professors suggests longevity gains across all states and regions for people born between 1941 and 2000, in contrast to previous estimates suggesting a century of stagnation or even declines in parts of the South.

New research from the University of Maryland, Baltimore County (UMBC) reveals how two different parts of the brain's memory center team up in a key reward region to help mice-and likely humans-combine memories of places and contexts with the drive to pursue rewards.

A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive review in ExRNA that sorts out the diverse roles of extracellular vesicle-associated RNAs (EV-RNAs) in the development and progression of inflammatory bowel disease (IBD).

For decades, 'mental wellbeing' has been one of the most used, but least agreed upon, terms in mental health.

Heart failure affects more than 64 million people worldwide (1%–3% in the general adult population) and its prevalence is projected to increase.

A new study conducted at the University of Eastern Finland highlights the challenges faced by older immigrants in Finland when seeking social and healthcare services, employment and citizenship. The empirical socio-legal research was published in Retfaerd (Nordic Journal of Law and Justice).

Researchers from the University of California San Diego have found that local sales bans on flavored tobacco in California are associated with reduced youth vaping over time without increasing cigarette smoking.

New research by an interdisciplinary team in Lithuania has revealed a promising and unconventional approach to cartilage regeneration.

As health information and services become increasingly digital, it is more important than ever that people can find, understand, evaluate and use health information in everyday life.

When you choose a diet version of your favorite fizzy drink, you consume non-nutritive sweeteners, which taste sweet but - unlike sugar - contain no calories.

Intracellular transport is a vital process that allows cells to move proteins and other molecules to specific locations.

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal lean muscle mass loss as they lost weight across 6 months of treatment.